Yellow fever Virus (Live attenuated) Vaccine

Welcome to Dwaey, specifically on Yellow fever Virus (Live attenuated) Vaccine page.
This medicine contains important and useful components, as it consists of
Yellow fever Virus (Live attenuated) Vaccine is available in the market in concentration.

Generic Name of Yellow fever Virus (Live attenuated) Vaccine - Learn More

Yellow fever Virus (Live attenuated) Vaccine

Yellow fever Virus (Live attenuated) Vaccine Precaution - What You Need to Know

Before initiating Yellow Fever Virus (Live Attenuated) Vaccine, it is critical for patients to consult their healthcare provider to ensure that vaccination is appropriate for them. Certain individuals should approach vaccination with caution due to underlying medical conditions.

- Immune System Considerations: This vaccine should not be administered to individuals with weakened immune systems, including those with HIV/AIDS, those receiving immunosuppressive therapies, or those undergoing cancer treatment.
- Allergy Concerns: Patients who are allergic to any components of the vaccine, including egg proteins, gelatin, or other ingredients, should not receive this vaccine. Allergic reactions can range from mild to severe and include symptoms such as difficulty breathing, swelling of the face or throat, and hives.
- Pregnancy and Breastfeeding: Pregnant and breastfeeding women should consult their healthcare provider, as the vaccine may not be recommended during pregnancy unless travel to areas with a high risk of yellow fever is necessary. The vaccine's safety during breastfeeding is also uncertain, so the risks should be carefully weighed.
- Age Restrictions: This vaccine is generally recommended for individuals aged 9 months or older. For younger infants or those with special health considerations, alternative protective measures may be necessary.
- Pre-existing Health Conditions: People with pre-existing health issues, such as a history of Guillain-Barré syndrome, should discuss their medical history with their healthcare provider, as the vaccine could exacerbate some conditions.

Yellow fever Virus (Live attenuated) Vaccine Indication - Uses and Benefits

Yellow Fever Virus (Live Attenuated) Vaccine is primarily prescribed to prevent yellow fever, a viral disease transmitted by mosquitoes, particularly in tropical and subtropical regions of Africa and South America. Yellow fever can cause severe liver disease, jaundice, hemorrhaging, and in some cases, death. The vaccine is indicated in the following cases:
- Travel-Related Protection: Individuals traveling to areas where yellow fever is endemic or where outbreaks are occurring. This includes travelers to parts of sub-Saharan Africa, Central and South America.
- Occupational Exposure: Individuals working in laboratories or environments where yellow fever virus may be handled.
- Epidemic Control: Health professionals may recommend vaccination during yellow fever outbreaks to curb transmission in affected areas.

Vaccination is considered a safe and effective way to prevent the spread and consequences of yellow fever.

Yellow fever Virus (Live attenuated) Vaccine Contraindications - Important Warnings

Yellow Fever Virus (Live Attenuated) Vaccine should not be administered under certain conditions, as it can lead to serious complications. Contraindications include:
- Severe Allergy to Vaccine Components: Individuals who have experienced a severe allergic reaction (anaphylaxis) to any component of the vaccine, such as egg protein or gelatin, should not receive it.
- Weakened Immune System: Those with immunodeficiencies, such as HIV/AIDS, or those receiving immunosuppressive treatments, should avoid this vaccine due to an increased risk of adverse reactions.
- Pregnancy: Pregnant women should avoid the vaccine, except in situations where travel to high-risk areas is unavoidable and no other preventive measures are available. The safety of the vaccine during pregnancy has not been well-established.
- Age Restrictions: The vaccine is contraindicated in infants younger than 9 months, due to the increased risk of severe reactions in this age group.
- Guillain-Barré Syndrome History: If a person has a history of Guillain-Barré syndrome, the vaccine should not be given, as it may increase the risk of recurrence.

Yellow fever Virus (Live attenuated) Vaccine Side Effects - What to Expect

Yellow Fever Virus (Live Attenuated) Vaccine is generally safe, but as with any vaccine, side effects can occur. Most side effects are mild and temporary, but some can be more serious. Common side effects include:
- Mild Reactions:
- Pain, redness, or swelling at the injection site.
- Mild fever or headache.
- Fatigue or muscle aches.

- Severe Reactions:
- Allergic Reactions: Anaphylaxis, although rare, can occur. Symptoms include difficulty breathing, swelling of the face or throat, and hives.
- Neurological Complications: In very rare cases, neurological reactions such as encephalitis or Guillain-Barré syndrome may occur.
- Viscerotropic Disease: A severe form of yellow fever that can cause organ failure, this side effect is very rare but can be fatal.

- Yellow Fever Vaccine-Associated Disease: Some individuals may develop a serious reaction known as "yellow fever vaccine-associated neurotropic disease" (YEL-AND), which can result in fever, headache, and neurological symptoms.

Patients should monitor for any signs of serious reactions and seek immediate medical attention if they experience difficulty breathing, swelling, or any neurological symptoms following vaccination.

Yellow fever Virus (Live attenuated) Vaccine Pregnancy Category ID - Safety Information

3

Yellow fever Virus (Live attenuated) Vaccine Mode of Action - How It Works

The Yellow Fever Virus (Live Attenuated) Vaccine works by stimulating the immune system to produce a protective response against the yellow fever virus. It contains a weakened (attenuated) form of the virus that cannot cause the disease in healthy individuals. Upon administration, the body recognizes the virus as a foreign pathogen and mounts an immune response. This includes:
- Production of Antibodies: The immune system generates antibodies that specifically target the yellow fever virus, providing immunity to future infections.
- Cell-Mediated Immunity: In addition to antibody production, the vaccine triggers T-cell responses that help recognize and destroy any infected cells, providing further protection.
Once the immune system has been exposed to the vaccine, it can quickly respond to and neutralize the yellow fever virus if the person is later exposed to it.

Yellow fever Virus (Live attenuated) Vaccine Drug Interactions - What to Avoid

The Yellow Fever Virus (Live Attenuated) Vaccine may interact with certain medications, leading to reduced effectiveness or increased risk of adverse effects. Key interactions include:
- Immunosuppressive Drugs: Medications that suppress the immune system, such as corticosteroids, chemotherapy drugs, or immunomodulators, may interfere with the effectiveness of the vaccine and increase the risk of adverse reactions. These drugs can impair the body’s ability to generate an immune response to the vaccine.
- Other Vaccines: Live vaccines, such as measles, mumps, rubella (MMR), or varicella vaccines, should generally be spaced out by at least 4 weeks. The concurrent administration of multiple live vaccines can affect the body’s immune response to each.
- Blood Products: The use of blood products, including immunoglobulin therapy, may interfere with the vaccine's effectiveness if administered within a few weeks before or after vaccination. It is recommended to delay vaccination until the effects of blood product administration have worn off.
- Herbal Supplements: Some herbal supplements, such as echinacea and ginseng, may affect immune function and potentially interact with live vaccines. Patients should inform their healthcare provider about any herbal supplements they are taking.

It is important for patients to inform their healthcare provider of all medications, including over-the-counter drugs and supplements, prior to receiving the vaccine.

Yellow fever Virus (Live attenuated) Vaccine Adult Dose - Recommended Dosage

The recommended dose for adults receiving the Yellow Fever Virus (Live Attenuated) Vaccine is a single injection of 0.5 mL administered subcutaneously or intramuscularly. The vaccine should be given at least 10 days before travel to a yellow fever-endemic area to ensure effective immunity.
- Booster Doses: A single dose of the vaccine typically provides lifelong protection, and booster doses are not usually required. However, some international regulations may require proof of vaccination within the past 10 years for certain travel.
- Special Considerations: In certain cases, such as for individuals with compromised immune systems, a healthcare provider may evaluate the risks and benefits of vaccination on a case-by-case basis.

Yellow fever Virus (Live attenuated) Vaccine Child Dose - Dosage for Children

For pediatric patients, the Yellow Fever Virus (Live Attenuated) Vaccine is typically administered at a dose of 0.5 mL. The vaccine is approved for use in children aged 9 months and older. For children under 9 months, the vaccine is generally contraindicated due to an increased risk of serious side effects, such as encephalitis or other neurological reactions.
- Dosing Schedule: A single dose of 0.5 mL is sufficient to provide long-term protection. In some cases, the vaccine may be administered to children older than 9 months in areas of yellow fever transmission.
- Safety Considerations: Parents or guardians should discuss with a healthcare provider any potential risks associated with the vaccine, especially in children with pre-existing health conditions or immunosuppression.

Yellow fever Virus (Live attenuated) Vaccine Renal Dose - Dosage for Kidney Conditions

There are no specific dose adjustments required for individuals with renal impairment when administering the Yellow Fever Virus (Live Attenuated) Vaccine. However, due to the potential for compromised immune response in individuals with severe renal disease, it is essential to consult a healthcare provider before vaccination. The vaccine may be contraindicated in people with significant immunosuppression, regardless of the underlying cause, which includes severe renal failure and dialysis patients.